Xifaxan can cost over $2,000/month without insurance. Here's every way to save in 2026 — manufacturer coupons, patient assistance programs, and more.
Let's not sugarcoat it: Xifaxan (Rifaximin) is one of the most expensive medications many patients will ever be prescribed. If you're taking it for hepatic encephalopathy, IBS-D, or another GI condition, you already know the sticker shock.
The good news? There are real ways to bring that cost down — sometimes dramatically. This guide walks through every savings option available in 2026, with actual dollar amounts so you know what to expect.
Here's the baseline you're working with:
For patients with hepatic encephalopathy who take Xifaxan as an ongoing maintenance medication, that's $19,200 to $26,400 per year at cash prices. Even with insurance, copays on a specialty-tier medication can run $200 to $500 per month.
There's no generic version available — and won't be until approximately 2028–2029. So savings programs are essential.
This is the first thing every commercially insured patient should look into.
How it works:
Who qualifies:
Potential savings: If your copay is $300/month, this card could reduce it to $0 — saving you $3,600 per year.
This is the single most impactful savings tool for commercially insured patients. If you haven't enrolled yet, do it today.
If you're uninsured or underinsured, the manufacturer's patient assistance program may provide Xifaxan at no cost.
How it works:
How to apply:
Potential savings: The full cost of medication — $1,600 to $2,200/month — covered entirely.
The PAN Foundation offers copay assistance for patients with financial need, including those on Medicare (which the manufacturer copay card doesn't cover).
How it works:
How to apply:
Potential savings: Varies, but can cover the majority of your copay — potentially saving $200 to $500/month.
If you're paying cash (no insurance), prescription discount cards can provide some savings — though the discounts on a brand-name-only medication like Xifaxan are more modest than for generics.
Options to check:
Potential savings: Typically $100 to $400 off cash price, depending on the pharmacy and card. Better than nothing, but these cards work best for generic medications.
Always compare prices across multiple cards and pharmacies — pricing varies significantly.
Some insurance plans offer lower copays for mail-order prescriptions. For HE patients who need Xifaxan monthly, switching to your plan's preferred mail-order pharmacy could save $50–$150 per fill.
Your gastroenterologist or hepatologist may have Xifaxan samples from the manufacturer. These can cover a few days to a couple of weeks of therapy — perfect for bridging a gap while you wait for PA approval or savings program enrollment.
If your insurance denies coverage for Xifaxan, don't give up. You have the right to appeal, and your doctor can submit a letter of medical necessity. First-level appeals are approved more often than patients expect — especially for hepatic encephalopathy where Xifaxan has strong guideline support.
Some states offer their own prescription assistance programs that supplement Medicare or Medicaid coverage. Search for your state's program at medicare.gov or through your state's health department website.
These nonprofit databases aggregate patient assistance programs, discount cards, and copay assistance across hundreds of medications including Xifaxan:
The most impactful price reduction would come from a generic Rifaximin — but that's not available yet. Xifaxan's patent exclusivity is projected to last through 2028–2029. When a generic does launch, prices are likely to drop by 50–80%, as is typical for brand-to-generic transitions.
Until then, the savings options above are your best tools.
No one should have to skip doses or abandon a prescription because of cost. If you're struggling to afford Xifaxan, start with the manufacturer copay card (commercially insured) or the Bausch Health Patient Assistance Program (uninsured). The PAN Foundation covers gaps for Medicare patients. And don't underestimate the value of appealing insurance denials — persistence pays off.
If finding Xifaxan in stock is part of the problem too, Medfinder can help you locate pharmacies near you with real-time availability. Check out our guide on how to find Xifaxan in stock for step-by-step tips.
For a broader look at what's happening with Xifaxan access, see our 2026 shortage update.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
